Literature DB >> 7790864

Overexpression of the neurotrophic cytokine S100 beta in human temporal lobe epilepsy.

W S Griffin1, O Yeralan, J G Sheng, F A Boop, R E Mrak, C R Rovnaghi, B A Burnett, A Feoktistova, L J Van Eldik.   

Abstract

Neuritic sprouting and disturbances of calcium homeostasis are well described in epilepsy. S100 beta is an astrocyte-derived cytokine that promotes neurite growth and induces increases in levels of intracellular calcium in neurons. In sections of neocortex of surgically resected temporal lobe tissue from patients with intractable epilepsy, we found that the number of S100 beta-immunoreactive astrocytes was approximately threefold higher than that found in control patients (p < 0.001). These astrocytes were activated, i.e., enlarged, and had prominent processes. Temporal lobe tissue levels of S100 beta were shown by ELISA to be fivefold higher in 21 epileptics than in 12 controls (p < 0.001). The expression of the astrocyte intermediate filament protein, glial fibrillary acidic protein, was not significantly elevated in epileptics, suggesting a selective up-regulation of S100 beta expression. Our findings, together with established functions of S100 beta, suggest that this neurotrophic cytokine may be involved in the pathophysiology of epilepsy.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7790864      PMCID: PMC3833622          DOI: 10.1046/j.1471-4159.1995.65010228.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  25 in total

1.  Increased S100 beta neurotrophic activity in Alzheimer's disease temporal lobe.

Authors:  D R Marshak; S A Pesce; L C Stanley; W S Griffin
Journal:  Neurobiol Aging       Date:  1992 Jan-Feb       Impact factor: 4.673

2.  S-100B but not NGF, EGF, insulin or calmodulin is a CNS serotonergic growth factor.

Authors:  E C Azmitia; K Dolan; P M Whitaker-Azmitia
Journal:  Brain Res       Date:  1990-05-21       Impact factor: 3.252

3.  Synthesis and expression of a gene coding for the calcium-modulated protein S100 beta and designed for cassette-based, site-directed mutagenesis.

Authors:  L J Van Eldik; J L Staecker; F Winningham-Major
Journal:  J Biol Chem       Date:  1988-06-05       Impact factor: 5.157

Review 4.  Glial fibrillary acidic protein (GFAP): the major protein of glial intermediate filaments in differentiated astrocytes.

Authors:  L F Eng
Journal:  J Neuroimmunol       Date:  1985-06       Impact factor: 3.478

Review 5.  Animal models of the epilepsies.

Authors:  R S Fisher
Journal:  Brain Res Brain Res Rev       Date:  1989 Jul-Sep

6.  S100 is present in developing chicken neurons and Schwann cells and promotes motor neuron survival in vivo.

Authors:  A Bhattacharyya; R W Oppenheim; D Prevette; B W Moore; R Brackenbury; N Ratner
Journal:  J Neurobiol       Date:  1992-06

7.  Increased neuronal beta-amyloid precursor protein expression in human temporal lobe epilepsy: association with interleukin-1 alpha immunoreactivity.

Authors:  J G Sheng; F A Boop; R E Mrak; W S Griffin
Journal:  J Neurochem       Date:  1994-11       Impact factor: 5.372

8.  Regulation by interleukin-1 of nerve growth factor secretion and nerve growth factor mRNA expression in rat primary astroglial cultures.

Authors:  M Carman-Krzan; X Vigé; B C Wise
Journal:  J Neurochem       Date:  1991-02       Impact factor: 5.372

9.  Epilepsy and the temporal lobes. A clinical, electroencephalographic and neuropathological study of the brain in epilepsy, with particular reference to the temporal lobes.

Authors:  J H Margerison; J A Corsellis
Journal:  Brain       Date:  1966-09       Impact factor: 13.501

10.  Neurite extension and neuronal survival activities of recombinant S100 beta proteins that differ in the content and position of cysteine residues.

Authors:  F Winningham-Major; J L Staecker; S W Barger; S Coats; L J Van Eldik
Journal:  J Cell Biol       Date:  1989-12       Impact factor: 10.539

View more
  36 in total

1.  Neuroinflammatory Cytokines-The Common Thread in Alzheimer's Pathogenesis.

Authors:  W Sue T Griffin; Steven W Barger
Journal:  US Neurol       Date:  2010

2.  Diagnostic value of Elecsys S100 as a marker of acute brain injury in the emergency department.

Authors:  Eun-Jee Oh; Young-Min Kim; Dong-Wook Jegal; Jimin Kahng; Yeon-Joon Park; Kyungja Han
Journal:  J Clin Lab Anal       Date:  2007       Impact factor: 2.352

Review 3.  S100B as a marker for brain damage and blood-brain barrier disruption following exercise.

Authors:  Serene X T Koh; Jason K W Lee
Journal:  Sports Med       Date:  2014-03       Impact factor: 11.136

4.  Age-dependent expression of S100beta in the brain of mice.

Authors:  Prashant K Modi; M S Kanungo
Journal:  Cell Mol Neurobiol       Date:  2010-01-23       Impact factor: 5.046

5.  Cloning, overexpression, purification, and spectroscopic characterization of human S100P.

Authors:  A Gribenko; M M Lopez; J M Richardson; G I Makhatadze
Journal:  Protein Sci       Date:  1998-01       Impact factor: 6.725

6.  Correlation of astrocytic S100 beta expression with dystrophic neurites in amyloid plaques of Alzheimer's disease.

Authors:  R E Mrak; J G Sheng; W S Griffin
Journal:  J Neuropathol Exp Neurol       Date:  1996-03       Impact factor: 3.685

7.  Phase-Dependent Astroglial Alterations in Li-Pilocarpine-Induced Status Epilepticus in Young Rats.

Authors:  Adriana Fernanda K Vizuete; Matheus Mittmann Hennemann; Carlos Alberto Gonçalves; Diogo Losch de Oliveira
Journal:  Neurochem Res       Date:  2017-04-25       Impact factor: 3.996

8.  S100B Protein, A Damage-Associated Molecular Pattern Protein in the Brain and Heart, and Beyond.

Authors:  Guglielmo Sorci; Roberta Bianchi; Francesca Riuzzi; Claudia Tubaro; Cataldo Arcuri; Ileana Giambanco; Rosario Donato
Journal:  Cardiovasc Psychiatry Neurol       Date:  2010-08-18

Review 9.  Interleukin-1 in the genesis and progression of and risk for development of neuronal degeneration in Alzheimer's disease.

Authors:  W Sue T Griffin; Robert E Mrak
Journal:  J Leukoc Biol       Date:  2002-08       Impact factor: 4.962

10.  Deletion of RAGE causes hyperactivity and increased sensitivity to auditory stimuli in mice.

Authors:  Seiichi Sakatani; Kazuyuki Yamada; Chihiro Homma; Seiichi Munesue; Yasuhiko Yamamoto; Hiroshi Yamamoto; Hajime Hirase
Journal:  PLoS One       Date:  2009-12-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.